Mark de Rosch - 19 Jan 2023 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Reporting relationship: Chief Operating Officer
Issuer ticker: AURA
Reported as of: 19 Jan 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Jan 2023, 17:36:39 UTC
Prior SEC filing: 02 Nov 2022
Next SEC filing: 23 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Julie Feder, as Attorney-in-Fact

Key filing fact

Mark de Rosch filed Form 4 for Aura Biosciences, Inc. (AURA) on 23 Jan 2023.

Key facts

This page summarizes Mark de Rosch's Form 4 filing for Aura Biosciences, Inc. (AURA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 Jan 2023, 17:36.

Change

Previous filing in this sequence was filed on 02 Nov 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AURA transaction

Common Stock

Award

Transaction value: $0
Shares: +42,250
Change %: +258%
Price: $0.000000
Shares after: 58,635
Date: 19 Jan 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AURA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +65,000
Change %
Price
Shares after: 65,000
Date: 19 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 65,000
Exercise price: $10.18
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant.

Footnote F2

The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of January 19, 2023 with the remainder vesting thereafter pro-rata in 36 monthly installments.